According to MarketsandMarkets™, the Cancer Diagnostics Market is projected to reach USD 44.92 billion by 2031 from USD 29.86 billion in ...

After a month of daily use, the MADE68 Ultra V2 impressed me with its gaming performance and software, but its typing feel ...

Qiagen also completed a $500 million share repurchase in January and raised its annual dividend 40% to $0.35 per share. The ...

CISF officer suspended after passengers confronted him over alleged secret photos of a woman inside a Delhi Metro coach.

Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may ...

Digital PCR (dPCR) partitions a sample into thousands of microscopic reactions to enable precise, highly sensitive quantification of nucleic acids. Its applications are wide-ranging and include rare ...

Shares of Molbio Diagnostics were currently trading at Rs 946.25 at 10:07 IST on the BSE, representing a premium of 17.26% as compared with the issue price of Rs 807.

For 2026, Qiagen reiterated expectations for 1–2% net sales growth at constant exchange rates and at least $2.43 in adjusted EPS, with third‑quarter sales seen up 1–2% and EPS of at least $0.62.

DELRAY BEACH, Fla., Aug. 12, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Cancer Tumor Profiling Market is projected to reach USD 19.87 billion by 2031 from USD 12.02 billion in 2026, at ...

Acknowledged that the Co-Dx PCR platform and related tests are currently subject to regulatory review and are not yet available for sale.

Stock market outlook Nifty 50. Nifty 50 ended the session at 24,366, down 29.85 points (-0.12%), after opening at 24,361.90, ...

The authentication of phototrophs and their derived products has become critical for food security, consumer safety, ...